Dolly firm struggles to survive
PPL Therapeutics, the biotechnology firm formed by the creators of Dolly the cloned sheep, faces liquidation this week, unless its shareholders back a last-minute survival plan. Chief executive Geoff Cook is holding a series of emergency meetings with investors, following news that the firm is to halt development of a...